Please sign in to follow a disease.
13,000 volunteers shed light on who gets sick from COVID-19
NCT ID NCT04330599
First seen Jul 17, 2026 · Last updated Jul 17, 2026
Summary
This large observational study follows 13,000 UK adults to understand who gets COVID-19, how the disease progresses, and its long-term effects on physical and mental health. Researchers track risk factors, symptoms, and outcomes like hospitalization. The data may also serve as a comparison group for future clinical trials.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- What this could lead to
- If successful, this study could identify who is most at risk for severe COVID-19 and help design future prevention trials.
- What could go wrong
- As an observational study, it cannot prove cause and effect. Results may be influenced by unmeasured factors or changes in the pandemic over time.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
About 13,000 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Apr 2020
- Expected to finish
-
Jul 2026
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
UK residents aged 16 years or more
- Ages
-
16 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * UK resident * Age ≥16 years Exclusion Criteria: none
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COVID-19 are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Queen Mary University of London
RECRUITINGLondon, County (optional), E1 2AB, United Kingdom
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- A single swab, two diseases: rapid test takes on TB and COVID-19
- A central vault for COVID-19 samples could speed up research
- Can a new vaccine bolster defenses against COVID-19?
- Can new vaccines outsmart COVID-19 variants?
- One shot for two threats: can a single vaccine stop flu and COVID?
- Door-to-Door help may increase COVID testing in Hard-to-Reach communities